Search Results
Found 2 results
510(k) Data Aggregation
(181 days)
Avalign Technologies, Inc.
The CONDUIT™ SYNFIX™ Evolution Secured Spacer System is a stand-alone anterior interbody fusion device with a microscope roughened surface and micro and nano-scale features indicated for use in patients with degenerative disc disease (DDD) at one or two contiguous levels from L2 to S1. These DDD patients may also have up to Grade I spondylolisthesis at the involved level(s). The interior of the spacer component of the CONDUIT SYNFIX Evolution can be packed with autograft. If used with less than the four integrated bone screws, or for hyperlordotic implants (>20Deg), implants must be used with supplemental fixation systems cleared by the FDA for use in the lumbosacral spine.
DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. These patients should be skeletally mature and have had six months of non-operative treatment.
The CONDUIT SYNFIX Evolution Secured Spacers are intervertebral body fusion devices intended for lumbar interbody fusion (ALIF). Four Screws are inserted through the anteriorly-located Plate into the adjacent vertebral bodies. The Screws lock securely to the Plate using a tapered-thread locking mechanism.
The CONDUIT SYNFIX Evolution Secured Spacer System is available as non-assembled Cage and Plate components in various heights and geometries to suit individual pathology and anatomical conditions. The Cage and Plate components are intended to be assembled at the point of use prior to implantation.
The CONDUIT SYNFIX Evolution Cages are made from Ti-6Al-4V ELI conforming to ASTM F3001 with an additive manufacturing process (Selective Laser Melting). The design contains solid structures and porous structures. The hollow geometry of the implants allows them to be packed with autogenous bone graft.
The 3D Printed Conduit Cellular Titanium Cages have a microscopic roughened surface with micro and nano-scale features. The micro and nano features are on all surfaces of the Cage, including the superior, inferior, and peripheral surfaces, as well as each member of the internal cell structure.
The provided text is a 510(k) clearance letter for a medical device called the "CONDUIT™ SYNFIX™ Evolution Secured Spacer System," which is an intervertebral body fusion device.
Crucially, this document is for a traditional medical device (an implantable hardware system), not an Artificial Intelligence (AI) or software-as-a-medical-device (SaMD) product.
Therefore, the information requested in the prompt, such as acceptance criteria for AI performance (e.g., sensitivity, specificity, AUC), sample sizes for test/training sets for AI, expert adjudication of AI ground truth, MRMC studies for AI, or standalone AI performance, is not applicable to this submission.
The acceptance criteria and study proving the device meets them, as described in this 510(k), relate to the mechanical performance, material properties, and biocompatibility of the physical interbody fusion device, not an AI algorithm.
Here's an analysis of the provided information relevant to the device's acceptance criteria and studies:
Acceptance Criteria and Device Performance (for a physical medical device):
The document mentions that mechanical testing was performed to "allow comparison with established acceptance criteria." While the specific numerical acceptance criteria (e.g., minimum load to failure, maximum displacement) are not explicitly detailed in the publicly available summary (which is common for 510(k) summaries), the types of tests conducted and the general conclusion indicate that the device met these criteria.
1. Table of Acceptance Criteria and Reported Device Performance (as inferred for a physical device):
Acceptance Criteria Category | Reported Device Performance (Summary) |
---|---|
Mechanical Integrity | Performed per ASTM F2077-24 (Static and Dynamic Axial Compression, Compression Shear), ASTM F2267-24 (Subsidence), and Expulsion |
MR Compatibility | Evaluated per ASTM F2052-21 (Magnetically Induced Displacement Force), ASTM F2213-17 (Magnetically Induced Torque), ASTM F2119-24 (MR Image Artifact), and ASTM F2182-19e2 (RF-induced Heating) to support MR Conditional labeling. |
Biocompatibility | Implied to be equivalent to predicate devices, as materials are medical grade titanium (Ti-6Al-4V ELI, Ti-6Al-4V, Ti-6Al-7Nb) which are well-established for this application. Specific tests not detailed but generally required for implants. |
Sterility | Implied to be equivalent to predicate devices. Specific tests not detailed but generally required. |
2. Sample size used for the test set and the data provenance:
- Sample Size: Not specified in the summary document. For mechanical testing of medical devices, "sample size" refers to the number of physical device units tested for each configuration or stress condition. These studies are typically conducted in a laboratory setting.
- Data Provenance: Laboratory testing (mechanical, MR compatibility). The country of origin of the data is not specified but is typically internal lab data or contracted third-party lab data.
- Retrospective or Prospective: Not applicable in the traditional sense for physical device testing. The tests are designed to assess the device's properties under simulated conditions.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not Applicable. This pertains to AI/software performance evaluation. For physical device testing, "ground truth" is established by calibrated measuring equipment and standardized test methods (e.g., ASTM standards). The "experts" are typically engineers and technicians responsible for conducting the tests and interpreting the results against pre-defined engineering acceptance criteria.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
- Not Applicable. This relates to human expert consensus for AI ground truth labeling. For mechanical testing, the results are objective measurements from testing equipment validated against industry standards.
5. If a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- Not Applicable. This is specific to AI/software for diagnostic or image-interpretation tasks. No such study was conducted or required for this physical device.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- Not Applicable. This is specific to AI/software.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):
- For mechanical testing, the "ground truth" is derived from standardized test methods (e.g., ASTM F2077, F2267) that define specific performance thresholds based on mechanical properties (e.g., ultimate strength, displacement within limits) and material science. The goal is to demonstrate that the device performs equivalently to predicate devices under defined mechanical loads and environmental conditions.
8. The sample size for the training set:
- Not Applicable. This pertains to AI model development.
9. How the ground truth for the training set was established:
- Not Applicable. This pertains to AI model development.
Conclusion from the 510(k) Summary:
The manufacturer "demonstrated substantial equivalence" by showing that their device performs mechanically and in terms of MR compatibility similarly to legally marketed predicate devices, and that the materials and design are appropriate for the intended use. The reliance on established ASTM standards and comparison to predicate devices are the primary methods for demonstrating safety and effectiveness for this type of medical implant.
The summary explicitly states: "No clinical data was necessary to demonstrate substantial equivalence, nor safety and effectiveness of this system." This further confirms that the evaluation was based on non-clinical (mechanical, material, and MR compatibility) testing and comparison to predicates.
Ask a specific question about this device
(276 days)
Avalign Technologies, Inc.
The Steripack case and tray system are intended for use in healthcare facilities to organize, enclose, sterilize, transport, and store medical devices and other instrumentation between surgical and other medical uses.
The Steripack case and tray system are not intended on their own to maintain sterility; they are intended to be used in conjunction with a legally marketed, validated, FDA-cleared sterilization wrap.
Sterilization validation for the worst-case Steripack cases and tray system included surgical instrument such as rongeur forceps, endoscopes, wrenches, cutters, pliers, etc. The Steripack cases and tray system were validated for up to a 9.35 lb (4.24 kg) load of metal instruments and polymer handled instruments.
Steripack Case and Tray Systems are utilized to secure medical instruments during transport, storage and processing (cleaning and sterilization). Orthopedic instruments and implants used in medical procedures are held in preconfigured cases and trays to facilitate transport to and from surgery and during cleaning and sterilization processes.
Some of the Case/Tray Systems in the Steripack line are preconfigured for a specific type instrument or surgical procedure. Other Cases/Trays in the Steripack line have components that are sold separately so the system can be configured based on the use.
Each Steripack Case and Tray Systems consist of multiple components designated to be integrated into a single unit. Which protects the interior components during the transportation, processing, and storage. All the component of the Steripack Case and Tray Systems are perforated with an evenly distributed hole pattern and are designed for stem sterilization. Since the Steripack Case and Tray Systems are perforated, an FDA cleared wrap must be used for sterilization purposes and to maintain the sterility of the contents. The Steripack Case and Tray Systems are designed to be used with standard autoclaves used in the hospitals and healthcare facilities.
The information provided describes the acceptance criteria and results of nonclinical testing for the "Steripack Case and Tray Systems" device. This is a medical device, and the evaluation focuses on its physical characteristics, durability, sterilization efficacy, and biocompatibility, rather than diagnostic performance or human-in-the-loop aspects. Therefore, some of the requested categories, such as sample size for test set, data provenance, number of experts, adjudication method, MRMC studies, standalone performance, and training set details, are not applicable in this context.
Here's a summary of the available information:
1. Table of Acceptance Criteria and Reported Device Performance
Name of the Methodology and Citation Name | Purpose | Acceptance Criteria | Results |
---|---|---|---|
Handle Durability Test | |||
ANSI/AAMI ST77:2006(R)2010 | To determine the ability of the case handle to maintain the lid to base connection when subjected to typical forces experienced during routine use. Tested on U type, rail style, and ring style handles. | 50 lb load to be held for 30 minutes (safety factor of 2X max load of 25 lbs). Source: ANSI/AAMI ST77:2006(R)2010 indicates maximum load for reusable case and trays are 25 lbs. | The three handle styles were able to support the 50 lb load for the required 30 minutes without failure. Therefore, the handle designs meet the requirements of ANSI/AAMI ST77:2006(R)2010 and the handles are safe and effective for use with the Steripack case and tray systems. |
Transport / Shipping Test | |||
ASTM D4169-09 | To determine the ability of the Steripack Case and Tray Systems to withstand the shipping and storage requirements during product shipping and transportation. Tests conducted: Manual Handling, Vehicle Stacking, Loose-load Vibration, Low Pressure Hazard, Vehicle Vibration, and Concentrated Impact. | The case system will be considered to be acceptable if it meets the following acceptance criteria: | |
• Instruments must remain in their designated location inside the outer case and lid system. | |||
• There must be no damage to the case/tray that would prevent it from holding and protecting the instruments for transport or sterilization processing. | |||
• There must be no damage to the internal instruments. | |||
Source: ASTM D4169-09 | Manual Handling: Acceptance criteria were met, instruments were held, no damage was inflicted on the case and tray system or the enclosed instruments. | ||
Vehicle Stacking: Acceptance criteria were met, instruments were held, no damage was inflicted on the case and tray system or the enclosed instruments. | |||
Loose-load Vibration: Acceptance criteria were met, instruments were held, no damage was inflicted on the case and tray system or the enclosed instruments. | |||
Low Pressure Hazard: Acceptance criteria were met, instruments were held, no damage was inflicted on the case and tray system or the enclosed instruments. | |||
Vehicle Vibration: Acceptance criteria were met, instruments were held, no damage was inflicted on the case and tray system or the enclosed instruments. | |||
Concentrated Impact: Acceptance criteria were met, instruments were held, no damage was inflicted on the case and tray system or the enclosed instruments. | |||
Life Cycle Testing / Repeated Reprocessing | |||
ANSI/AAMI ST77:2006(R)2010 | To demonstrate that the Steripack Case and Tray system could withstand repeated reprocessing through a steam sterilization cycle. | After the 100 sterilization cycles the case and tray materials of construction must be durable and compatible with the sterilization process: | |
• No materials may break down. | |||
• All handles, latches, and hinges must move freely and as intended. | |||
• No visible rust or discoloration is acceptable on laser etching. | |||
• Screen print cannot bleed, peel, or shift. | |||
• No visible discoloration is acceptable on stainless steel or anodized components. | |||
• Cracking nylon coating or exposed metal through nylon is not acceptable. | |||
• Radel and polypropylene cannot be deformed. | |||
Source: Test was conducted to show materials meet the durability and sterilization compatibility requirements of ANSI/AAMI ST77:2006(R)2010. | After 100 cycles were complete, all functional testing and material requirements described above passed. The only observation made was four of the nylon coated brackets had the nylon coating begin to bubble. This was not deemed a functional failure because the nylon coating did not crack and no metal was exposed. | ||
Sterilant penetration | |||
AANSI/AAMI/ISO 17665-1:2006/(R)2013 | To validate the sterilization efficacy of the Steripack case and tray worst-case volume to vent ratio device, when processed fully loaded in a steam pre-vacuum sterilization cycle at 132° C (270°F) with four (4) minutes of exposure time. | The overkill method was selected to verify the sterilization efficacy of the samples, per AAMI/ISO guidelines. In this method, validation was accomplished by demonstrating that a minimum of 1.0 x 10^6 highly resistant Geobacillus stearothermophilus spores were killed in a half-cycle (6-log reduction). A full cycle would therefore result in a 12-log reduction of spores and produce a 10^-6 SAL, which reflects a one-in-a-million chance of a non-sterile item. | |
Source: AANSI/AAMI/ISO 17665-1:2006/(R)2013 | Results from testing validate that the Steripack Instrument Tray and Case Systems allow sterilant penetration sufficient to achieve a 10^-6 SAL after processing in the pre-vacuum sterilization cycle at 132°C (270°F) and four (4) minutes of exposure time. | ||
Biocompatibility – Thermoplastic Coating (Nylon 11) | |||
ANSI/AAMI/ISO 10993-5:2009 | Testing performed on the Thermoplastic Coating as manufactured to ensure it meets the Cytotoxicity (MEM elution test) requirements of ISO 10993 for a device with potential indirect patient contact. | Grade ≤ 2 | |
Source: ANSI/AAMI/ISO 10993-5:2009 | Test specimen was subjected to a cytotoxicity test ISO MEM elution L-929 cells (ATCC CCL-1). Method: Incubated at 37±1° C with 5±1% CO2 for 72 ± 3 hours. The test article scored a Grade 0, eliciting no cytotoxic effect. | ||
Biocompatibility – Thermoplastic Coating (Nylon 11) | |||
ANSI/AAMI/ISO 10993-1:2009 | Testing performed on the Thermoplastic Coating to ensure it meets the Acute Systemic Toxicity requirements of ISO 10993 for a device with potential indirect patient contact. | No clinical signs of toxicity during the 72 hour study period. | |
Source: ANSI/AAMI/ISO 10993-1:2009 | Acute Systemic Toxicity test on mice. Method: The extraction mixtures and corresponding control blanks were incubated for 72 ± 2 hours at 50 ± 2 °C. None of the animals on study were observed with abnormal clinical signs indicative of toxicity during the 72 hour test period. All were alive at the end of the 72 hour test duration and body weight loss was within acceptable parameters over the course of the study. | ||
Biocompatibility – Thermoplastic Coating (Nylon 11) | |||
ANSI/AAMI/ISO 10993-1:2009 | Testing performed on the Thermoplastic Coating to ensure it meets the Intracutaneous Irritation requirements of ISO 10993 for a device with potential indirect patient contact. | Extract from the test specimen must not cause local irritation to the dermal tissue of a rabbit. | |
Source: ANSI/AAMI/ISO 10993-1:2009 | Test specimen was subjected to an Acute Systemic Toxicity test on mice. Method: The extraction mixtures and corresponding control blanks were incubated for 72 ± 2 hours at 50 ± 2 °C. No significant dermal reactions were observed in the test subjects. | ||
Biocompatibility – Thermoplastic Coating (Nylon 11) | |||
ANSI/AAMI/ISO 10993-1:2009 | Testing performed on the Thermoplastic Coating to ensure it meets the Implantation Test requirements of ISO 10993 for a device with potential indirect patient contact. | The differences between average scores of the encapsulation of the test article implantation site and the negative control site cannot score greater than 1.0. | |
Source: ANSI/AAMI/ISO 10993-1:2009 | Test specimen was subjected to an intramuscular implantation test on rabbits. The test article was implanted in the animal subject for 1 week. Method: test article was cut into pieces approximately 3 mm x 10 mm. and instead to the paravertebral muscle. There was no difference (Score of 0) between the average encapsulation scores between the implantation sites and the negative control sites. | ||
Biocompatibility – Thermoplastic Coating (Nylon 11) | |||
ANSI/AAMI/ISO 10993-5:2009 | Testing performed on the Thermoplastic Coating after sterilization to ensure it meets the Cytotoxicity (MEM elution test) requirements of ISO 10993 for a device with potential indirect patient contact through leachables. | Grade ≤ 2 | |
Source: ANSI/AAMI/ISO 10993-5:2009 | The test article induced no cytotoxicity (Grade 0). Therefore the test article is not considered to elicit a cytotoxic effect under the conditions employed. | ||
Biocompatibility – Silicone (Elastomer) | |||
ANSI/AAMI/ISO 10993-5:2009 | Testing performed on the Silicone Elastomer material to ensure it meets the Cytotoxicity requirements of ISO 10993 for a device with potential indirect patient contact. | No cytopathic effect. | |
Source: ANSI/AAMI/ISO 10993-5:2009 | Cytotoxicity testing reports were provided by the supplier (DOW CORNING). Per biocompatibility reports, "Cell Culture" test was performed on "Elastomers" and "Cell culture medium extract of elastomer" for the cytotoxicity evaluation. No Cytopathic effect (morphology changes). No Cytopathic effect (morphology changes): ≥ 75% visibility (by neutral red). | ||
Biocompatibility – Silicone (Elastomer) | |||
ANSI/AAMI/ISO 10993-10:2009 | Testing performed on the Silicone Elastomer material to ensure it meets the Sensitization requirements of ISO 10993 for a device with potential indirect patient contact. | No sensitization when exposed to an extract of the test article. | |
Source: ANSI/AAMI/ISO 10993-10:2009 | Skin Sensitization test was performed on Elastomer, Saline Extract of elastomer and Ethanol or acetone extract of elastomer for the sensitization evaluation. Test meets ISO 10993-1 requirements with no sensitization. | ||
Biocompatibility – Silicone (Elastomer) | |||
ANSI/AAMI/ISO 10993-10:2009 | Testing performed on the Silicone Elastomer material to ensure it meets the Intracutaneous Reactivity requirements of ISO 10993 for a device with potential indirect patient contact. | Test article to be non-irritating and non-toxic. | |
Source: ANSI/AAMI/ISO 10993-10:2009 | Intracutaneous reactivity test was performed on Saline Extract of elastomer, Extract if elastomer in 5% ethanol 95% saline, PEG 400 extract of elastomers and Cottonseed oil extract of elastomer for the intracutaneous reactivity evaluation. The test article was non-irritating and non-toxic relative to controls. | ||
Biocompatibility – Silicone (Elastomer) | |||
ANSI/AAMI/ISO 10993-10:2009 | Testing performed on the Silicone Elastomer material to ensure it meets the Systemic Toxicity requirements of ISO 10993 for a device with potential indirect patient contact. | Test article to be non-irritating and non-toxic. | |
Source: ANSI/AAMI/ISO 10993-10:2009 | Systemic toxicity test was performed on Saline Extract of elastomer, Extract if elastomer in 5% ethanol 95% saline, PEG 400 extract of elastomers and Cottonseed oil extract of elastomer for the intracutaneous reactivity evaluation. The test article was non-irritating and non-toxic relative to controls. | ||
Biocompatibility – Silicone Elastomer | |||
ANSI/AAMI/ISO 10993-5:2009 | Testing performed on the eight color variations of the Silicone elastomer after sterilization to ensure it meets the Cytotoxicity (MEM elution test) requirements of ISO 10993 for a device with potential indirect patient contact through leachables. | Grade ≤ 2 | |
Source: ANSI/AAMI/ISO 10993-5:2009 | All samples met the requirement for a Grade ≤ 2. Specific results for each coupon: | ||
• Test Coupon: Black Silicone Extrusion: Grade 0 | |||
• Test Coupon: Blue Silicone Extrusion: Grade 1 | |||
• Test Coupon: Blue V- Rubber Extrusion: Grade 1 | |||
• Test Coupon: Black Pin Mat: Grade 0 | |||
• Test Coupon: Blue Pin Mat: Grade 2 | |||
• Test Coupon: Flat Bottom Black Pin Mat: Grade 0 | |||
• Test Coupon: Flat Bottom Blue Pin Mat: Grade 0 | |||
• Test Coupon: Grid Pin Mat: Grade 0 | |||
Biocompatibility – Anodized Aluminum | |||
ANSI/AAMI/ISO 10993-5:2009 | Testing performed on the Anodized Aluminum material to ensure it meets the Cytotoxicity requirements of ISO 10993 for a device with potential indirect patient contact. | Grade ≤ 2 | |
Source: ANSI/AAMI/ISO 10993-5:2009 | Test article was subjected to a cytotoxicity test ISO MEM elution L-929 cells (ATCC CCL-1). Method: Incubated at 37±1° C with 5±1% CO2 for 48 ± 3 hours. The test article scored "0" at 48 ± 3 hours for all 3 cell monolayers. | ||
Biocompatibility – Anodized Aluminum | |||
AANSI/AAMI ST 72:2011 | Testing performed on the Anodized Aluminum material to ensure it meets the requirements of ANSI/AAMI ST 72 for pyrogenicity. | For a medical device, endotoxin limit is >20 EU/device. | |
Source: AANSI/AAMI ST 72:2011 | Test specimen was subjected to a BET test. Method: The extraction was performed by immersing the test article in endotoxin free water and placing it on an orbital shaker in an incubator for 40-60 minutes at 37 - 40°C. The range for the three specimens was 20 EU/device. | ||
Source: ANSI/AAMI ST 72:2011 | Test specimen was subjected to a BET test. Method: The extraction was performed by immersing the test article in endotoxin free water and placing it on an orbital shaker in an incubator for 40-60 minutes at 37 - 40°C. The range for the three specimens was |
Ask a specific question about this device
Page 1 of 1